Azithromycin NDC 70518-3254

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-3254Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-3254Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70518-3254-1	70518325401	2 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3254-1)Marketed from Jan 14, 2022
70518-3254-2	70518325402	2 POUCH in 1 BOX (70518-3254-2) / 1 TABLET, FILM COATED in 1 POUCH (70518-3254-3)Marketed from Feb 10, 2022
70518-3254-4	70518325404	3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3254-4)Marketed from May 10, 2022
70518-3254-5	70518325405	5 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3254-5)Marketed from May 12, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Azithromycin
Generic name (nonproprietary): azithromycin
Active ingredients: Azithromycin dihydrate — 500 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211792
Marketing start: Oct 23, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Macrolides (Chemical structure)
Identifiers: Product ID 70518-3254_584fd2ea-a23d-8dfe-e063-6394a90a13f7SPL ID 584fd2ea-a23d-8dfe-e063-6394a90a13f7SPL set ID 614cc2a4-3fc7-455d-9e8a-212c496f0fbfRxCUI 248656UNII 5FD1131I7S
Pharmacologic class: Macrolide Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518325401 followed by a unit qualifier and the quantity

Package 70518-3254-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 5, 2026.

Indications (excerpt from the label)

Azithromycin tablets are a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications [see Dosage and Administration (2)]. Azithromycin tablets are a macrolide antibacterial drug indicated for mild to moderate infections caused by designated, susceptible bacteria: • Acute bacterial exacerbations of chronic bronchitis in adults (1.1) • Acute bacterial sinusitis in adults (1.1) • Uncomplicated skin and skin structure infections in adults…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211792

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211792
Product	Strength	Form · route	Labeler	Product NDC
Azithromycin	Azithromycin dihydrate 500 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-252
Azithromycin	Azithromycin dihydrate 500 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-058